Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Multicenter Trial, Examining the Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.

NCT07209475 is registered in ClinicalTrials.gov with Royal Biologics as lead sponsor.

NCT NCT07209475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07209475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Multicenter Trial, Examining the Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
Lead sponsor
Royal Biologics
Phase
Phase 4
Overall status
Recruiting
Start date
August 14, 2025
Completion date
August 14, 2026
Enrollment
248 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

amnio-maxx, diabetic foot ulcer (dfu)